Key TakeawaysThe FDA has approved the first drug that can both treat and prevent migraines.Nurtec ODT was initially approved for acute use—to treat an existing migraine—in February of last year.According to experts, there are now many medications and products available to help people prevent their migraines. Key Takeaways The FDA has approved the first drug that can both treat and prevent migraines.Nurtec ODT was initially approved for acute use—to treat an existing migraine—in February of last year....

Key Takeaways Last week, the U.S. Food and Drug Administration (FDA) approved glucagon, the first generic medication to treat severe hypoglycemia. The injectable medication can help those with very low blood sugar, which can occur in people with diabetes. It will be packaged as an emergency kit intended for use when blood sugar drops to dangerous levels. Injectable glucagon has been approved in the U.S. for more than two decades, but there hasn’t been an authorized generic version of the drug....

Key TakeawaysThe FDA has approved an injectable drug, Cabenuva, for the treatment of HIV in adults.Cabenuva is administered once a month in the form of a shot. It represents an alternative to current standard-of-care oral medication regimens requiring a pill be taken every day.Doctors and researchers expect Cabenuva to have broad appeal. Key Takeaways The FDA has approved an injectable drug, Cabenuva, for the treatment of HIV in adults.Cabenuva is administered once a month in the form of a shot....

Key TakeawaysThe FDA approved the first drug to treat metabolic dysfunction-associated steatohepatitis (MASH).The medication, called Rezdiffra (resmetirom), is expected to be available next month.Up until now, there was no treatment for MASH. Patients were advised to lose weight or adopt lifestyle changes. Key Takeaways The FDA approved the first drug to treat metabolic dysfunction-associated steatohepatitis (MASH).The medication, called Rezdiffra (resmetirom), is expected to be available next month.Up until now, there was no treatment for MASH....

Key TakeawaysPhexxi, a gel, is a new type of non-hormonal birth controlIt’s intended to be used only when you need itAn early study suggests it’s less effective than IUDs or birth control pills Key Takeaways Phexxi, a gel, is a new type of non-hormonal birth controlIt’s intended to be used only when you need itAn early study suggests it’s less effective than IUDs or birth control pills Until last month, there hadn’t been any major innovation in non-hormonal birth control since the IUD was invented in the 1970s....

Key TakeawaysRegulators approved an oral once-daily drug, called Sotyktu (ducravacitinib) for treating moderate to severe plaque psoriasis.Clinical trials showed that the drug is more effective and better tolerated than the twice-daily oral psoriasis drug, Otezla (apremilast).An oral medication may be easier for patients to take than injectable biologics. Key Takeaways Regulators approved an oral once-daily drug, called Sotyktu (ducravacitinib) for treating moderate to severe plaque psoriasis.Clinical trials showed that the drug is more effective and better tolerated than the twice-daily oral psoriasis drug, Otezla (apremilast)....

Key TakeawaysOpzelura (ruxolitinib), the first topical cream to treat vitiligo, recently gained FDA approval.Based on data from the clinical trials, 30% of the participants regained at least 75% skin repigmentation on their face.People who have the condition can now request Opzelura from a board-certified dermatologist. Key Takeaways Opzelura (ruxolitinib), the first topical cream to treat vitiligo, recently gained FDA approval.Based on data from the clinical trials, 30% of the participants regained at least 75% skin repigmentation on their face....

Key TakeawaysThe FDA has approved Vivjoa to treat recurrent yeast infections in infertile and post-menopausal people.Vivjoa is taken orally, via a capsule.The medication is available through a prescription. Key Takeaways The FDA has approved Vivjoa to treat recurrent yeast infections in infertile and post-menopausal people.Vivjoa is taken orally, via a capsule.The medication is available through a prescription. The Food and Drug Administration (FDA) hasapproved Vivjoa, an antifungal medication that is designed to reduce recurrent yeast infections in women with a history of the condition....

Key TakeawaysThe FDA approved Lynparza (olaparib), a pill from AstraZeneca for the treatment of adult patients with high-risk early breast cancer.The drug is used for people who have responded well to or have been treated with chemotherapy.Patients can only use the drug if they are selected for therapy based on criteria from the FDA.Common side effects of the drug include nausea, fatigue, anemia, vomiting, headache, and diarrhea. Key Takeaways The FDA approved Lynparza (olaparib), a pill from AstraZeneca for the treatment of adult patients with high-risk early breast cancer....

Key TakeawaysThe U.S. Food and Drug Administration approved Semglee, a biosimilar form of insulin.As a generic, it can be automatically swapped for the price brand-name versions to help patients save money.Doctors applaud the move, saying it addresses a major cost barrier for people with diabetes. Key Takeaways The U.S. Food and Drug Administration approved Semglee, a biosimilar form of insulin.As a generic, it can be automatically swapped for the price brand-name versions to help patients save money....

Key TakeawaysThe Food and Drug Administration (FDA) approvedXywavto treat adults with idiopathic hypersomnia, a rare sleep disorder where an individual does not get rest from sleeping.There are no other drugs approved in the United States to treat idiopathic hypersomnia.Xywav will only be available through certified healthcare providers and pharmacies. Key Takeaways The Food and Drug Administration (FDA) approvedXywavto treat adults with idiopathic hypersomnia, a rare sleep disorder where an individual does not get rest from sleeping....

Key TakeawaysThe FDA approved a continuous glucose monitor (CGM) that lasts up to six months.The system, Eversense E3, is now the longest lasting CGM in the world.CGMs help people track blood sugar levels and manage their diabetes. Key Takeaways The FDA approved a continuous glucose monitor (CGM) that lasts up to six months.The system, Eversense E3, is now the longest lasting CGM in the world.CGMs help people track blood sugar levels and manage their diabetes....

Key TakeawaysEli Lilly’s Mounjaro, a once-a-week injection treatment for type 2 diabetes, recently gained FDA approval.Experts say this medication represents a groundbreaking advancement in the diabetes community.The drug targets two major hormones that regulate blood sugar levels. Key Takeaways Eli Lilly’s Mounjaro, a once-a-week injection treatment for type 2 diabetes, recently gained FDA approval.Experts say this medication represents a groundbreaking advancement in the diabetes community.The drug targets two major hormones that regulate blood sugar levels....